The use of functional epirubicin liposomes to induce programmed death in refractory breast cancer
Lei Liu, Li-Min Mu, Yan Yan, Jia-Shuan Wu, Ying-Jie Hu, Ying-Zi Bu, Jing-Ying Zhang, Rui Liu, Xue-Qi Li, Wan-Liang Lu Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Be...
Enregistré dans:
| Auteurs principaux: | Liu L, Mu LM, Yan Y, Wu JS, Hu YJ, Bu YZ, Zhang JY, Liu R, Li XQ, Lu WL |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/6ffa3316fd20403a95fbf0055f3ed66b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Nicotine exacerbates tacrolimus-induced renal injury by programmed cell death
par: Yu Ji Jiang, et autres
Publié: (2021) -
Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma
par: Ju RJ, et autres
Publié: (2016) -
Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years
par: Farah Z, et autres
Publié: (2016) -
Augmentation uretero-enterocystoplasty for refractory urinary tract dysfunction: a long-term retrospective study
par: Xiaoqian Ying, et autres
Publié: (2021) - Refractories and industrial ceramics